Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Ossium Health

Ossium Health?uq=U5Zpp9ZJ
2016 FOUNDED
PRIVATE STATUS
11-20 EMPLOYEES
Series A LATEST DEAL TYPE
$10.4M LATEST DEAL AMOUNT
5 INVESTORS
Description

Developer of clinical research and cell therapy products designed to improve human health through driving innovation in biotechnology that fosters the preservation of life. The company's products cure leukemia and other blood diseases, as well as improve organ transplantation, treat radiation poisoning and heal tissue damage, enabling healthcare professionals to revolutionize bioengineering, with the ultimate goal of ending diseases.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Drug Discovery
Primary Office
  • 25 Taylor Street
  • San Francisco, CA 94102
  • United States

+1 (415) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Ossium Health’s full profile, request a free trial.

Ossium Health Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC (Series A) 24-May-2018 $10.4M 000.00 000.00 Completed Generating Revenue
3. Grant 01-Jan-2017 00000 000 Completed Startup
2. Corporate 30-Nov-2016 $7M $7M 0000 Completed Startup
1. Early Stage VC 18-Aug-2016 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Ossium Health Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series A3 00,000,000 00.000000 00 00.0 00.0 00 00.0 0.000
Series A2 0,000,000 00.000000 00 00.00 00.00 00 00.00 0.000
Series A1 17,489,492 $0.000001 8% $0.05 $0.05 1x $0.05 5.95%
Series A 30,661,523 $0.000001 8% $0.22 $0.22 1x $0.22 9.97%
To view this company’s complete Cap Table, request access »

Ossium Health Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Elevate Ventures Venture Capital Minority 000 0000 000000 0
National Institutes of Health Government 000 0000 000000 0
U.S. Department of Health and Human Services Government 000 0000 000000 0
AlloSource Corporation Minority 000 0000 000000 0
First Round Capital Venture Capital Minority 000 0000 000000 0

Ossium Health Executive Team (7)

Name Title Board
Seat
Contact
Info
Kevin Caldwell ESQ Co-Founder, Chief Executive Officer, President and Board Member
Erik Woods Ph.D Co-Founder, Chief Scientific Officer & Board Member
Margie Mathewson Director, Operations and Business Development
Brian Johnstone Director, Research & Development
David Sachs Co-Founder & Founding Scientific Advisor
You’re viewing 5 of 7 executives. Get the full list »

Ossium Health Board Members (5)

Name Representing Role Since Contact
Info
Bill Trenchard First Round Capital Board Member 000 0000
Erik Woods Ph.D Ossium Health Co-Founder, Chief Scientific Officer & Board Member 000 0000
Kevin Caldwell ESQ Ossium Health Co-Founder, Chief Executive Officer, President and Board Member 000 0000
Sebastian Giwa Ph.D Self Co-Founder, Chairman & Chief Strategy Officer 000 0000
Thomas Cycyota AlloSource Board Member 000 0000